Tinnitus Assessment and Rehabilitation Cost Planner Korea

Plan Korean tinnitus assessment, TRT, CBT, sound-device, and hearing-aid patient costs with quote-driven 3-, 12-, and 36-month scenarios and purchase-versus-rental guidance.

Health cost scenario inputs

Enter Korea-related chronic care, eldercare, therapy, procedure, fertility, diagnostic, or medical tourism assumptions. Results are simplified planning estimates.

Gross therapy program cost

₩1,920,000

Estimated support amount

₩0

Net therapy budget

₩1,920,000

Monthly therapy budget

₩160,000

2 sessions/month

This English page is a compact therapy scenario backed by a deeper South Korea-specific tinnitus cost guide. The exact Korean calculator keeps the consultation, basic audiology, additional hearing or tinnitus tests, clinician-selected CT or MRI, medicine, follow-up, TRT, CBT, sound generator, and hearing-aid quote separate. It projects 3, 12, and 36 months, compares purchase with rental, and caps confirmed initial, monthly, and device reimbursement at the corresponding cost subtotal. It does not use a nationwide average or infer private-indemnity payment from the insurance generation. KDCA patient information updated May 18, 2026 describes history, eardrum and hearing assessment, additional testing when needed, TRT education and counselling with sound therapy, and hearing aids when hearing loss is present; it also notes that no medicine is proven to directly cure tinnitus. Korean cost-sharing context was checked against National Health Insurance Act Article 44 effective January 2, 2026, Enforcement Decree Article 19 and Annex 2 effective February 19, 2026, and MOHW Notice 2026-141 effective July 1, 2026. NICE NG155 supplies supplementary safety and tinnitus-focused CBT guidance. This is budget planning, not diagnosis, emergency triage, treatment or device advice, an insurer decision, or a reimbursement guarantee. Verified July 24, 2026.

Related calculators

Why there is no single tinnitus treatment price in Korea

Tinnitus is hearing a sound without a matching external source, and the assessment path changes with the sound pattern, hearing status, associated symptoms, and suspected cause.
Korea's Disease Control and Prevention Agency health portal describes history-taking, questionnaires, eardrum examination, pure-tone audiometry, and speech audiometry as core assessment components.
Impedance testing, auditory brainstem response, otoacoustic emissions, tinnitus matching, CT, or MRI may be added when clinically indicated rather than ordered as one universal package.

This planner therefore does not invent a nationwide average or recommend a standard number of rehabilitation visits.
It organizes patient-pay quotes from a Korean hospital, counsellor, or device provider into initial assessment, recurring medical care, tinnitus retraining therapy (TRT), cognitive behavioural therapy (CBT), sound-device, and hearing-aid layers.
The result is a personal cash-flow scenario, not a diagnosis, clinical recommendation, reimbursement guarantee, or prediction that treatment will remove tinnitus.

A zero is an unfilled quote, not proof that care is free

Replace each zero with the patient amount on a provider estimate or the detailed itemized bill.
If several tests are sold or billed as one bundle, enter that quote once in the closest field instead of duplicating it across several categories.

Check clinical urgency before comparing costs

Many people with persistent tinnitus can be assessed through a scheduled appointment, but some combinations of symptoms should take priority over budget planning.
The safety prompts summarize referral timing from NICE guideline NG155 in plain language and do not determine the cause of tinnitus.

Tinnitus safety signal and assessment priority
Situation selectedPriority shownWhat to do with the planner
Sudden neurological signs or uncontrolled acute severe vertigoImmediate medical assessmentStop cost comparison and prioritize urgent care
Tinnitus with hearing loss that developed suddenly over 3 days or less within the past 30 daysAssessment within 24 hoursPrioritize an ENT assessment over routine quote shopping
Persistent unilateral pulsatile tinnitusPrompt specialist assessmentConfirm the clinician-selected imaging path first

Leaving every box clear does not guarantee safety

New weakness, speech difficulty, severe headache, inability to walk, rapidly changing hearing, or any symptom that feels dangerous needs medical advice regardless of this output.
If tinnitus-related distress becomes unbearable or includes thoughts of self-harm, seek immediate human and clinical support instead of continuing a financial exercise alone.

How to separate the initial assessment quote

The initial subtotal adds the consultation and only the test groups that the user selects.
A patient's actual amount can vary with provider type, covered or non-covered status, equipment, contrast media, test scope, and other services billed on the same day.
Use the estimate from the provider that will perform the assessment rather than a price copied from an unrelated clinic.

Basic audiology

Group the eardrum examination, pure-tone audiometry, speech audiometry, or closely related basic tests listed by the booked provider.
This evaluates hearing type and level; it is not merely a measurement of how loud the tinnitus feels.

Additional hearing and tinnitus tests

Enter impedance, auditory brainstem response, otoacoustic emissions, tinnitus matching, or another additional test only when it appears in the individualized plan.
Listing these options does not mean every patient needs all of them.

CT or MRI

A clinician chooses the modality and region when the tinnitus pattern or examination suggests a neural, structural, or vascular cause.
Include imaging only after confirming the patient quote, contrast plan, and Korean NHI billing status.

TRT, CBT, sound therapy, and recurring care

KDCA patient information describes tinnitus retraining therapy as education and counselling combined with sound therapy.
Sound may come from the environment, a phone, a sound generator, or—when hearing loss is present and the device is suitable—a hearing aid.
NICE recommends a stepped psychological approach for tinnitus-related distress, moving through digital, group, and individual tinnitus-focused CBT according to need and access.

TRT sessions

Ask whether counselling, education, audiology review, and sound-therapy setup are already bundled into the per-session price.
Do not enter a package as both a monthly amount and repeated session amount, because the planner would count it twice.

CBT sessions

Treat this field as a budget for managing tinnitus-related distress, sleep, attention, and behavioural responses, not as a promise to silence the sound.
Digital, group, and individual delivery can carry different prices, so enter the mode actually offered to the patient.

Medicine and follow-up

KDCA notes that there is no medicine proven to directly cure tinnitus, although a prescription may address a related condition, anxiety, depression, or sleep difficulty.
Enter only the monthly patient amount from the prescription and follow-up plan; never use this budget to start, stop, or adjust medicine without the prescriber.

Formula and a reproducible 12-month example

Each projection assumes that the entered monthly frequency and unit prices remain unchanged for the selected number of months.
Confirmed reimbursement is capped at its matching initial, monthly medical, or device subtotal so that the patient result cannot become negative.

Initial assessment = consultation + selected basic + additional + imaging patient amounts

Monthly care = medicine + follow-up count × unit price + TRT count × unit price + CBT count × unit price

Selected device = purchase + monthly maintenance × months, or rental setup + monthly rental × months

Gross total = initial assessment + monthly care × months + selected sound device + hearing-aid quote

Net patient cost = gross total - applicable confirmed reimbursement

Test vector, not an average Korean price

Assume KRW 30,000 for consultation, KRW 70,000 for basic audiology, KRW 100,000 for additional testing, and no imaging.
Monthly care is KRW 20,000 medicine, one KRW 30,000 follow-up, two TRT sessions at KRW 80,000 each, and one CBT session at KRW 100,000, totalling KRW 310,000 per month.
Select a KRW 600,000 sound-device purchase with KRW 10,000 monthly maintenance, then enter confirmed reimbursement of KRW 50,000 initially and KRW 100,000 per month.

Reproducible three, twelve, and thirty-six month tinnitus budget example
HorizonGross totalConfirmed paymentNet patient cost
3 monthsKRW 1,760,000KRW 350,000KRW 1,410,000
12 monthsKRW 4,640,000KRW 1,250,000KRW 3,390,000
36 monthsKRW 12,320,000KRW 3,650,000KRW 8,670,000

Purchase versus rental break-even

Purchase cost is the purchase quote plus monthly maintenance over the horizon, while rental cost is setup plus monthly rental over the same horizon.
A break-even month exists only when monthly rental exceeds monthly purchase maintenance.
With a KRW 600,000 purchase, KRW 10,000 monthly maintenance, KRW 100,000 rental setup, and KRW 70,000 monthly rental, the rounded-up simple break-even point is 9 months.

Included in the comparison

  • Purchase price and entered monthly maintenance
  • Rental setup charge and monthly rental
  • Simple cash outlay at 3, 12, and 36 months

Review outside the formula

  • Minimum term and early-cancellation charge
  • Refundable deposit and return policy
  • Fitting, repair, consumables, and warranty
  • Clinical suitability and the planned trial period

The cheaper cash path is not necessarily the appropriate device path.
A supervised trial, fitting quality, comfort, and contract exit terms may matter more than the arithmetic break-even point.

Korean NHI and private indemnity insurance

National Health Insurance Act Article 44 establishes patient cost sharing, and Enforcement Decree Article 19 points to the detailed rules in Annex 2.
Actual patient liability still varies by provider level, service, outpatient or inpatient setting, special reduction, and whether an item is covered, selectively covered, full self-pay, or non-covered.
The current source set checked for this calculator includes the Act effective January 2, 2026, the Decree and Annex 2 effective February 19, 2026, and Ministry of Health and Welfare Notice 2026-141 effective July 1, 2026.

The planner does not multiply a sticker price by a generic 30%, 40%, 50%, or 60% rate.
It asks for the patient amount already quoted by the Korean provider because mixed covered and non-covered bills, especially tertiary outpatient bills, cannot be represented reliably by one percentage.
Private indemnity generation is retained as a consultation note only; reimbursement changes the result only after the insurer or support program confirms an initial, monthly, or device payment.

Verify the bill, not an assumed percentage

  1. Obtain the receipt and detailed itemized statement from the provider.
  2. Identify covered patient share, full self-pay, and non-covered items.
  3. Consider HIRA's non-covered fee confirmation service when appropriate.
  4. Ask the private insurer for item-specific expected payment and document requirements.
  5. Do not subtract support twice when it is already reflected in a net device quote.

Step-by-step use

  1. Review safety signals first.Act on the displayed medical priority before continuing with routine budget planning.
  2. Copy the hospital quote by category.Avoid duplicate test entries and include imaging only when it is part of the clinician-selected path.
  3. Enter recurring care from the actual schedule.Check whether a TRT package already contains counselling, sound setup, or follow-up.
  4. Compare device quotes on matching terms.Align tax, fitting, warranty, consumables, and maintenance inclusions.
  5. Subtract confirmed payments only.An insurance generation or application by itself is not a confirmed reimbursement amount.
  6. Refresh the 3-, 12-, and 36-month scenarios.Recalculate whenever session frequency, device mode, price, or reimbursement changes.

Frequently asked questions

Does every person with tinnitus need an MRI?

No.
A clinician selects CT, MRI, another test, or no imaging after considering the tinnitus pattern, hearing results, and examination.
Selecting imaging here only adds an already-recommended patient quote to the budget.

Does TRT guarantee that tinnitus will disappear?

No outcome is predicted by this calculator.
TRT combines education, counselling, and sound therapy to address the reaction and burden associated with tinnitus, with individualized goals and duration.

Can both a hearing aid and a sound generator be entered?

Yes, if they are two separate confirmed purchases in the plan.
If one hearing aid includes a sound-generator feature in a single quote, enter that amount once rather than duplicating the device price.

Does selecting fourth-generation indemnity insurance calculate a payout?

No.
Product terms, limits, exclusions, riders, deductibles, and claim review differ, so only a payment confirmed for the specific item changes the result.

Is the projection the final treatment bill?

It is a scenario that holds the entered monthly schedule and prices constant.
Added tests, session changes, discontinuation, adverse-effect care, price changes, and unrelated medical costs are not predicted, so update it when the plan changes.

Sources and effective dates

The clinical overview follows KDCA's Korean National Health Information Portal page on tinnitus, updated May 18, 2026.
Korean cost-sharing context was checked against National Health Insurance Act Article 44 effective January 2, 2026, Enforcement Decree Article 19 and Annex 2 effective February 19, 2026, and MOHW Notice 2026-141 effective July 1, 2026.
NICE NG155 supplies supplementary referral and tinnitus-focused CBT guidance.

Sources were checked on July 24, 2026.
Laws, notices, insurance terms, provider prices, and support programs can change, so recheck the rules effective on the date of care or contract.

Turn confirmed quotes into a comparable plan

Enter the assessment, monthly rehabilitation, device, and confirmed payment layers to compare the same scenario at 3, 12, and 36 months.
Reconcile the result with itemized bills, and make testing and treatment decisions with the responsible clinician.